Cyberonics Inks 2 Collaborations – Analyst Blog
Source: http://www.zacks.com/stock/news/25578/Cyberonics+Inks+2+Collaborations+-+Analyst+BlogPosted on Wednesday, October 7th, 2009 | In Investing Lessons, Stocks to Watch
Cyberonics, Inc. (CYBX) entered into two collaboration agreements in the field of EEG-based seizure detection technology to bolster its leadership position in epilepsy. The collaborations are with NeuroVista Corporation and the Massachusetts Institute of Technology.
The License Agreement with NeuroVista Corporation entered on Oct 1, 2009 provides Cyberonics with access to a wide range of technology and patents in exchange for payments extending through Apr 2011. Details regarding the payments have not yet been disclosed.
The NeuroVista technology includes an algorithm for seizure detection, a rechargeable battery system, wireless communication, and an implantable lead and will help Cyberonics accelerate its development of an implantable pulse generator. NeuroVista Corporation is an early-stage medical device company pioneering new technologies in the management and treatment of epilepsy, a central nervous system disorder characterized by loss of consciousness and convulsions.
In early 2009, Cyberonics entered into an Exclusive Patent License Agreement and a Research Agreement with the Massachusetts Institute of Technology. The agreement calls for licensing two patent applications related to EEG-based seizure detection and sponsor related research.
The financial transactions include minimal upfront and annual payments and royalty payments based on net sales of the licensed product. The two collaborations will enable Cyberonics to incorporate new technology into future generations of the Vagus Nerve Stimulation (VNS) Therapy System.
Cyberonics is a neuromodulation company that develops and markets the VNS Therapy System for the treatment of refractory epilepsy and treatment-resistant depression. The VNS Therapy improves the patient’s quality of life by minimizing seizure reduction.
Read the full analyst report on “CYBX”
Zacks Investment Research
Last 5 posts by Zacks Market Commentaries
- CNP & FPL Ink Pipeline Deal - Analyst Blog - November 20th, 2009
- Buffett Borrows for Rail Acquisition - Analyst Blog - November 20th, 2009
- Stone Energy Outdoes Estimates - Analyst Blog - November 20th, 2009
- Smucker's Beats, Raises Guidance - Analyst Blog - November 20th, 2009
- GameStop Meets Expectations - Analyst Blog - November 20th, 2009
convulsions, Cyberonics, Depression, epilepsy, Investing Lessons, loss of consciousness, Massachusetts, massachusetts institute of technology, medical device company pioneering new technologies, nervous system disorder, NeuroVista Corporation, Seizure, Stocks to Watch, treatment of epilepsy, wireless communication, Zacks Market Commentaries
 About Zacks Market Commentaries (http://www.zacks.com/)
Zacks Market Commentaries |
No recommendations, either expressed or implied, are being made to buy, sell, hold or short any of the mentioned stocks. No legal, tax or accounting advice is expressed or implied. Always contact your attorney, CPA, or tax advisor before acting on any legal or tax issues. StraightStocks.com is not responsible for the content, products, or services of any of the advertisers on this site. StraightStocks.com receives compensation from advertisers on this blog. Services and products referred to herein are trademarks, registered trademarks, servicemarks, and/or registered servicemarks of their respective trademark or servicemark owners.